Management of malignant pleural mesothelioma—part 2: therapeutic approaches: Consensus of the Austrian Mesothelioma Interest Group (AMIG)

Management of malignant pleural mesothelioma—part 2: therapeutic approaches: Consensus of the Austrian Mesothelioma Interest Group (AMIG)

Treatment of malignant pleural mesothelioma (MPM) depends on performance status of the patient, tumor stage, and histological differentiation. Chemotherapy (CHT) can be administered as first- and second-line treatment in unresectable MPM or as neoadjuvant or adjuvant treatment before or after surger...

Full description

Bibliographic Details
Main Authors: Hoda, Mir Alireza, Klikovits, Thomas, Arns, Madeleine, Dieckmann, Karin, Zöchbauer-Müller, Sabine, Geltner, Christian, Baumgartner, Bernhard, Errhalt, Peter, Machan, Barbara, Pohl, Wolfgang, Hutter, Jörg, Eckmayr, Josef, Studnicka, Michael, Flicker, Martin, Cerkl, Peter, Klepetko, Walter
Format: Online
Language:English
Published: Springer Vienna 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033993/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033993/

Similar Items